Since the 1960s, the dream of ultra-fast high dose radiation promised better cancer treatment with fewer side effects. Will the reality measure up?
n: A run of mutations in a tumor genome that don’t offer any particular survival advantage.
New T cell therapies succeed with a narrow band of cancers. Can they be made to work for the rest of them, too?
One way to get drugs through the blood-brain barrier: smuggle them across using sound waves.
In theory, smart microscopic particles could evade defenders and home in on cancer targets. Will reality catch up to the hype?
The far-flung tumors of tuberous sclerosis complex, noncancerous but hardly benighn, are shedding light on how malignancies develop.